Sean A McGhee
Affiliation: University of California
- Persistent parvovirus-associated chronic fatigue treated with high dose intravenous immunoglobulinSean A McGhee
Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Pediatr Infect Dis J 24:272-4. 2005..Prolonged intravenous immunoglobulin therapy resulted in resolution of his symptoms and viremia. Intravenous immunoglobulin may be useful in the resolution of parvovirus viremia regardless of immune status...
- Two-tiered universal newborn screening strategy for severe combined immunodeficiencySean A McGhee
Department of Pediatrics Immunology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
Mol Genet Metab 86:427-30. 2005..Sensitivity was 85% for IL-7 screening and 100% for TREC screening. A two-tiered strategy may be of sufficient accuracy to enable universal SCID screening, and should be assessed in a prospective trial...
- Potential costs and benefits of newborn screening for severe combined immunodeficiencySean A McGhee
Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095 1752, USA
J Pediatr 147:603-8. 2005..SCID is a candidate for universal newborn screening, so there is a need to determine under which circumstances screening would be cost-effective...
- Genome-wide testing: genomic medicine: commentary on the article by Bar-Shira et al. on page 353Sean A McGhee
Department of Pediatrics, David Giffin School of Medicine, Mattel Children s Hospital, University of California, Los Angeles, CA 90095, USA
Pediatr Res 60:243-4. 2006
- Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 yearsAntonia Kwan
Department of Pediatrics, University of California San Francisco and UCSF Benioff Children s Hospital, San Francisco, CA 94143 0519, USA
J Allergy Clin Immunol 132:140-50. 2013..Assay of T-cell receptor excision circles (TRECs) in dried blood spots obtained at birth permits population-based newborn screening (NBS) for severe combined immunodeficiency (SCID)...
- Immunologic reconstitution in 22q deletion (DiGeorge) syndromeSean A McGhee
Department of Pediatrics, Division of Pediatric Immunology, David Geffen School of Medicine at UCLA, MDCC 12 430, Los Angeles, CA 90095 1752, USA
Immunol Res 45:37-45. 2009..Adoptive transfer should be pursued as a reasonable treatment for 22qDS patients requiring immune reconstitution when thymus transplant is not available...
- How the practice of allergy shows the promise and challenge of personalized medicineSean A McGhee
Department of Pediatrics, Immunology and Allergy, 269 Campus Drive, CCSR Bldg Rm 2115, Stanford, CA 94305, USA
Mol Genet Metab 104:3-6. 2011..Individualized therapy has always been central to the practice of allergy, and so provides a useful proving ground for personalized medicine as a concept of care...
- Long-term results of bone marrow transplantation in complete DiGeorge syndromeMichael H Land
Department of Pediatrics, University of California at Los Angeles Medical Center, Los Angeles, CA 90095, USA
J Allergy Clin Immunol 120:908-15. 2007..Thymic transplantation has shown promising results but is not easily available. Hematopoietic cell transplantation (HCT) has been successful in restoring immune competence in the short term...